个体化放疗进展__培训课件.pptVIP

中国人口按13.6亿计算 * * The pharmacogenetics has many clinical potentials. Patients with the same diagnosis are typically treated with the same manner, although their responses to drug therapy will not be the same. Phamacogenetics has the potential to provide a tool for predicting those patients who are likely to have the desired response to the drug, those who are likely to have little or no benefit and those at risk for toxicity. This will allow tailored therapy that should reduce adverse reactions to drugs and increase efficacy rates. * 试验设计如下：临床分期为II-III期的颈段、胸中上段食管鳞癌患者，治疗前获取并保留肿瘤组织，然后接受西妥昔单抗、紫